Press release from Companies: Inhalation Sciences receives new order worth 62 000 EURO from University of Vienna

Press release from Companies: Inhalation Sciences signs IRS contract worth 1.39 million SEK with new US respiratory pharma client

Press release from Companies: Inhalation Sciences: clarification to previous press releases (published Jan 18, May 5, Aug 4, 2022) regarding the planned FDA study

Press release from Companies: Kommuniké från extra bolagsstämma i Inhalation Sciences Sweden AB (publ)

Press release from Companies: Inhalation Sciences receives new order worth 360,000 SEK from long-term global pharma client

Press release from Companies: Inhalation Sciences AB (publ) publicerar delårsrapport för det andra kvartalet 2022

Press release from Companies: Inhalation Sciences AB (publ) releases Q2 Report 2022

Press release from Companies: KALLELSE TILL extra bolagsstämma i INHALATION SCIENCES SWEDEN AB (PUBL)

Press release from Companies: Forthcoming changes in Inhalation Sciences’ Board of Directors

Press release from Companies: Förestående ändringar i Inhalation Sciences styrelse

Press release from Companies: Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US

Press release from Companies: Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US